Avai Bio annual operating margin
2020
2023
Avai Bio's operating margin was −126.28% for fiscal 2023.
View full Avai Bio company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-03-31 | −126.28% | −131.13 pp |
| 2020 | 2020-03-31 | 4.85% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2021 | 2020-12-31 | 134.76% | — |
| Q2 2021 | 2020-09-30 | −7.12% | — |
| Q1 2021 | 2020-06-30 | 8.13% | — |
Across the available reported history, Avai Bio's operating margin decreased from 4.85% to −126.28%, a change of −131.13 percentage points. The latest reported quarter, Q3 2021, shows 134.76%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Avai Bio filings at SEC.gov ↗